<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "octreotide inj VIAL>
<dose><value>1 - 10</value>
<value>10 - 40</value>
<value>1 - 2</value>
<value>1</value>
<value>50</value>
<value>100 - 500</value>
<value>100 - 600</value>
<value>50 - 1500</value>
<value>200 - 300</value>
<value>150 - 750</value>
<value>50 - 100</value>
<value>1 - 30</value>
<value>1 - 1.5</value>
<value>100</value>
</dose><route><value>IV</value>
<value>SC</value>
</route><form><value>inj VIAL</value>
</form><drug><value>octreotide inj VIAL</value>
</drug><strength><value>200 mcg/mL</value>
<value>500 mcg/mL</value>
</strength><frequency><value>Q6H</value>
<value>CONTINUOUS</value>
<value>TID</value>
<value>ONCE</value>
<value>Q12H</value>
<value>Q8H</value>
<value>Q24H</value>
</frequency><instruction><value></value>
<value>Administer by continuous infusion. Titrate to desired effect.</value>
<value>Administer daily calculated dose in 3 equally divided doses.</value>
<value>Administer by continuous infusion. Titrate dose to response.</value>
<value>Administer daily calculated dose in 2 equally divided doses.</value>
<value>Administer daily calculated dose in 4 equally divided doses.</value>
<value>Administer by direct injection.</value>
<value>Administer by continuous infusion.</value>
<value>based upon blood glucose concentrations.</value>
<value>may repeat dose in 6 hours as needed based upon blood glucose concentrations.</value>
<value>may repeat dose in 12 hours as needed based upon blood glucose concentrations.</value>
<value>for 7 days. Initiate treatment on day of operation at least one hour pre-operatively.</value>
</instruction><volume><value>5 mL</value>
<value>1 mL</value>
</volume><units><value>mcg/kg/dose</value>
<value>mcg/kg/hour</value>
<value>mcg/kg/day</value>
<value>mcg/kg</value>
<value>mcg</value>
<value>mcg/day</value>
<value>mcg/hour</value>
</units><additionalnotes><value>MAXIMUM DOSE: 10 mcg/kg/dose every 6 hours</value>
<value>Chyle production should decrease significantly within 24 hours.</value>
<value>Titrate dose as required in 5 to 10 mcg/kg/day increments every 3 to 4 days up to 40 mcg/kg/day.</value>
<value>Initial dose, follow with continuous IV infusion.</value>
<value>Reduce dose by 50% every 12 hours when no active bleeds occur for 24 hours. May stop infusion when dose is 25% of initial dose.</value>
<value>Initiate dose at low range and titrate to repsonse.</value>
<value></value>
<value>Dosage adjustments are made monthly on growth hormone levels, symptoms and patient tolerability. MAXIMUM: 1500 mcg/day.</value>
<value>Suggested dosing during the first 2 weeks.</value>
<value>Experience with daily doses above 750 mcg is limited.</value>
<value>Recommended for first 2 weeks of treatment.</value>
<value>Follow initial dose with continuous IV infusion.</value>
<value>Maximum recommended infusion duration is 72 hours.</value>
</additionalnotes><population><value>NEONATE: Hyperinsulinemic hypoglycemia</value>
<value>NEONATE: Chylothorax.</value>
<value>INFANT / CHILDREN: GI Bleed / Esophageal Varices. </value>
<value>INFANT / CHILDREN: Diarrhea</value>
<value>ADULT: Acromegaly.</value>
<value>ADULT: Carcinoid Tumors.</value>
<value>ADULT: VIPoma</value>
<value>ADULT: Bleeding Esophageal Varices</value>
<value>ADULT: Hypoglycemia in Oral Hypoglycemic Poisoning.</value>
<value>NEONATE: Diarrhea</value>
<value>NEONATE: high output secretory diarrhea</value>
<value>INFANT / CHILDREN: Treatment of Oral Hypoglycemic Overdose. </value>
<value>ADULT: Prevention of complications following pancreatic surgery.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>AHS Drug Formulary Restrictions:Acute Care: Restricted to the treatment of: 1) suspected or confirmed bleeding of esophageal varices, 2) prevention of post-operative complications following pancreatic surgery, 3) acromegaly, 4) control of symptoms in patient s with vasoactive intestinal peptide secreting tumors (VIPoma) or metastatic carcinoid syndrome.</value>
</backgroundinformation><prninformation><value></value>
<value>YES</value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions, Usage guidelines.</value>
</ahsformularystatus><ahfsname><value>Other Miscellaneous Therapeutic Agents</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>